News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–87
Matches
87
Sources here
12
Companies here
1
Search results Stored financial headlines

Active search

87 matching headlines

Ticker or company: ALHCMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kaplan Fox is Investigating Claims on Behalf of Alignment Healthcare, Inc. (ALHC) Investors for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of accounting irregularities that artificially inflated the company's financial results. This news led to a significant drop in Alignment Healthcare's stock price. …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy With 18% Potential Upside

Alignment Healthcare, Inc. (ALHC) is presented as a compelling investment opportunity in the healthcare sector, particularly appealing to growth-oriented investors. With a market capitalization of $4.36 billion, the company focuses on Medicare Advantage plans for seniors, showing strong revenue growth of 33.30% and an …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Notifies Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower complaint alleged "accounting irregularities" that artificially inflated the company's financial results and executive compensation. Following news of the complaint on July 8, 2026, Alignment …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALIGNMENT HEALTHCARE INVESTOR ALERT: Bragar Eagel & Squire,

Bragar Eagel & Squire, P.C. is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following allegations of financial manipulation. A former executive filed a whistleblower lawsuit claiming the company misclassified operating expenses as capital expenditures to inflate its adjusted EBITDA and stock price. Following …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALHC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Kirby McInerney LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities laws violations. This follows a whistleblower lawsuit alleging that Alignment Healthcare manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its stock price and executive compensation. The firm …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Block & Leviton probes Alignment Healthcare for alleged securities violations after whistleblower lawsuit.

Block & Leviton is investigating Alignment Healthcare (ALHC) for alleged securities violations, stemming from a whistleblower lawsuit. The lawsuit claims the company manipulated financial results to inflate its stock price and executive compensation. This follows a significant 16.72% stock drop after the lawsuit news, …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alignment Hea

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following a whistleblower lawsuit. The lawsuit alleges that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures to artificially inflate its adjusted EBITDA, leading to a significant drop …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges accounting irregularities that falsely inflated the company's financial results, specifically through misclassifying operating expenses as capital expenditures. This news led …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Announces a Securities Investigation into Alignment Healthcare, Inc. (ALHC) - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP has launched a securities investigation into Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities" that "artificially inflated" the company's financial results. The complaint suggests that operating expenses were misclassified as capital expenditures, leading to …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare (NASDAQ: ALHC) president trades 177K shares, exercises options

Alignment Healthcare's president, Dawn Christine Maroney, exercised options for 152,068 shares at $9.06 per share and subsequently sold 177,068 shares at a weighted-average price of $20.8281 per share under a Rule 10b5-1 trading plan. The transactions, which occurred on July 15, 2026, resulted in …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now

Alignment Healthcare (ALHC) is poised for growth due to its strong balance sheet and significant investments in automation and AI, which are enhancing operational efficiency and expanding margins. However, the company faces near-term challenges from the transition to the CMS V28 risk adjustment model …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Reminds Investors of an Ongoing Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges "accounting irregularities" that "artificially inflated" the company's financial results by misclassifying operating expenses as capital expenditures. Following this news on …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALHC (NASDAQ: ALHC) insider plans sale of 177,068 common shares

A Form 144 filing indicates a proposed sale of 177,068 shares of Alignment Healthcare (ALHC) common stock with an aggregate market value of over $3.7 million. These shares originate from stock options exercised and RSU/PSU awards, and the sale will be facilitated by Morgan …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment healthcare CEO John Kao sells $5.9m in ALHC shares

John E. Kao, CEO of Alignment Healthcare (NASDAQ:ALHC), sold 298,000 shares worth approximately $5.92 million on July 10, 2026, through a pre-arranged trading plan. This sale occurred while the stock declined 15% over the past week but remains up 52% over the last year. …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Look at Alignment Healthcare Inc (ALHC) After 4.0% Gain -- GF Value $19.34 vs Price $21.21

Alignment Healthcare Inc (ALHC) shares gained 4.0% to $21.21, but are considered 9.7% overvalued according to GuruFocus' GF Value of $19.34. The stock has a GF Score of 78/100, indicating good long-term potential, though profitability and momentum scores are low. Insider selling totaling $15.8 …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context